EPCAM and non-small cell lung carcinoma: Here, we evaluated the expression of PD-L1, EGFR, rVAR2, and EpCAM on different NSCLC cell lines and concluded that the combined use of rVAR2 and EpCAM enhances the efficiency of immunomagnetic enrichment for tumor cells with varying levels of target expression.